▲ Up
 
00:40 24-07-2017
АКИpress CA-News Tazabek Turmush
ADVERTISE WITH US SUBSCRIBE
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion
16:29, 20 June 2014, 1275

AKIPRESS.COM - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Full access to all news articles in English

1 month2000 somsubscribe
year20000 somsubscribe
These subscription fees are for private individuals only. Please contact us via phone +996 (312) 900-776 or email info@akipress.org for corporate subscription inquiries
Twitterfacebookprint
LATEST NEWS
18:08 'Turkey hasn't open its doors to those who shot at their own people after 2010 events in Kyrgyzstan' – adviser to president of Turkey17:02 Przhevalsky Museum to be rehabilitated in Karakol16:50 PM Jeenbekov orders to finish construction of schools by new academic year16:05 662 mln som allocated for rehabilitation of Balykchy — Korumdu road out of planned 912 mln — Ministry of Transport15:29 Atambayev, ex–chairman of El Kurultai of Altai Republic discuss cooperation15:12 Palestinian President to freeze contact with Israel ‘on all levels’14:03 813.2 million som allocated for motorway repairs in H113:15 Kyrgyz Embassy asks migrants in Russia to deliver biometric data12:12 Tender for construction of burnt building of General Prosecutor's Office of Kyrgyzstan announced again11:36 Three Israelis stabbed to death in West Bank attack11:05 Cargo transportation between Kyrgyzstan and Kazakhstan 14% up10:14 Tourists from Chelyabinsk use 6-10 day tours to Issyk-Kul - Delegation of Chelyabinsk09:36 Tajikistan to promote clothing to counter ‘alien’ traditions09:17 India musician plays guitar during brain surgery09:05 Mortality rate among children under 5 years old down two-thirds: First Lady17:55 PM Jeenbekov orders to accelerate rehabilitation of resort for teachers17:21 Minister of Transport of Kyrgyzstan calls on employees to work on weekends16:30 'Dunkirk': How historically accurate is Christopher Nolan's WWII battle film?16:30 Probe launched against 19yo boy who went to Issyk-Kul with 14yo girl16:10 Atambayev congratulates newly elected president of India
© AKIpress News Agency - 2001-2017. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75